title: Indications, surgical technique, and long-term functional results of colon interposition or bypass.
abstract: Over a 17-year period, 92 patients with esophageal disease underwent colon interposition or bypass, with each operation performed by the same surgeon. The indication was cure of cancer in 20 patients, relief of dysphagia in 55 (cancer in 17 patients and benign in 38), loss of gastrointestinal (G.I.) continuity in ten, and tracheoesophageal fistula in seven patients (malignant in five, benign in 2). The thirty-day operative mortality rate was 5%, and the hospital mortality rate was 9%. Graft necrosis occurred in seven of 92 patients, four of whom later underwent a successful second reconstruction. Thirteen patients required subsequent revisional surgery. In 85 patients, the left colon based on the inferior mesenteric artery was used, and in seven, the right colon was used. Technical insights were gained to help preserve the blood supply to the graft and improve its function in transporting food. Thirty-four patients were available for interview 2-17 years after operation (median of 5 years) 28 of whom had benign disease, and six of whom had malignant disease); 82% of the patients felt they were cured of their preoperative symptoms, 18% improved, and none worsened. Eighty-eight per cent of the patients were able to receive an unrestricted diet. All patients except one were satisfied with the results of surgery, and, asked what they would do if they had to make the choice again, all responded that they would have the operation. Twenty-six of the interviewed patients had their eating ability evaluated with a test meal and the transit time of a liquid and solid barium bolus measured. Compared to controls, patients with colon interpositions consumed a smaller capacity meal over a longer period of time and were not dependent on liquids to flush the food through the colon graft. A colon interposition provides good quality of deglutition, is very durable, and is the organ of choice for patients who require an esophageal substitute and are potential candidates for long survival.
authors.affiliation: Creighton University School of Medicine, Department of Surgery, Omaha, NE 68131.
authors.forename: T R
authors.initials: TR
authors.lastname: DeMeester
authors.forename: K E
authors.initials: KE
authors.lastname: Johansson
authors.forename: I
authors.initials: I
authors.lastname: Franze
authors.forename: E
authors.initials: E
authors.lastname: Eypasch
authors.forename: C T
authors.initials: CT
authors.lastname: Lu
authors.forename: J E
authors.initials: JE
authors.lastname: McGill
authors.forename: G
authors.initials: G
authors.lastname: Zaninotto
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003106:Colon / Q000637:transplantation*; D004435:Eating; D004935:Esophageal Diseases / Q000601:surgery; D004938:Esophageal Neoplasms / Q000601:surgery; D004944:Esophagoplasty / Q000379:methods*; D004947:Esophagus / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011859:Radiography; D012086:Reoperation